Advertisement

Conclusions

  • Irène Ceballos-Picot
Part of the Neuroscience Intelligence Unit book series (NIU.LANDES)

Abstract

As medical science has prolonged human life, it has also brought a sharp increase in the numbers of people suffering one of the most calamitous afflictions of old age. In this book, we have presented the rationale for the hypothesis that oxidative stress could be the common mediator of the entire pathologic cascade leading to neuronal death in major age-related neurodegenerative disorders. It is attractive to speculate that effective treatment, but above all prevention, of these diseases may be carried out by drugs operating at this important level of the pathogenic cascade. Lowering the ROS formation and thereby the associated ROS-damage by a large panel of antioxidants could be a challenge for the prevention of neurodegeneration.

Keywords

Thiol Disulfide Thioctic Acid Central Nervous System Trauma Pathogenic Cascade Lipid Antioxidant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    The Parkinson’s study group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease. New Engl J Med 1993; 328: 176–183.Google Scholar
  2. 2.
    Hantraye P, Brouillet E, Ferrante R et al. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat Med 1996; 2: 1017–1021.PubMedCrossRefGoogle Scholar
  3. 3.
    Hall ED, Braughler JM. Central nervous system trauma and stroke. II. Physiological and pharmacologic evidence for involvement of oxygen radicals and lipid peroxidation. Free Rad Biol Med 1989; 6: 303–313.Google Scholar
  4. 4.
    Mc Lachlan C, Dalton DR, Kruck TPA et al. Intramuscular desferrioxamine in patients with Alzheimer’s disease. Lancet 1991; 337: 1304–1308.CrossRefGoogle Scholar
  5. 5.
    Breitner JS, Gau BA, Wilsh KA et al. Inverse association of antiinflammatory treatments and Alzheimer’s disease: initial results of a co-twin control study. Neurology 1994; 44: 227–232.PubMedCrossRefGoogle Scholar
  6. 6.
    Rogers J, Kirby LC, Hempelman SR. Clinical trial of indomethacin in Alzheimer’s disease. Neurology 1993; 43: 1609–1611.PubMedCrossRefGoogle Scholar
  7. 7.
    Mc Geer PL, Mc Geer E, Rogers J, Sibley J. Antiinflammatory drugs and Alzheimer’s disease. Lancet 1990; 335: 1037.Google Scholar
  8. 8.
    Marx J. Searching for drugs that combat Alzheimer’s. Science 1996; 273: 50–53.Google Scholar
  9. 9.
    Frim DM, Wullner U, Beal MF, Isacson O. Implanted NGF-producing fibroblasts induce catalase and modify ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatum. Exp Neurol 1994; 8: 172–180.CrossRefGoogle Scholar
  10. 10.
    Jackson GR, Sampath D, Werrbach-Perz K, Perez-Polo JR. Effect of nerve growth factor on catalase and glutathione peroxidase in a hydrogen peroxide-resistant pheochromocytoma subclone. Brain Res 1994; 634: 69–76.PubMedCrossRefGoogle Scholar
  11. 11.
    Mattson MP, Lovell MA, Furukawa K, Markesbery WR. Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca“ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J Neurochem 1995; 65: 1740–1751.PubMedCrossRefGoogle Scholar
  12. 12.
    Grilli M, Pizzi M, Memo M et al. Neuro-protection by aspirin and sodium salicylate through blockade of NF-x13 activation. Science 1996; 274: 1383–1385.PubMedCrossRefGoogle Scholar
  13. 13.
    Packer L, Trizchler HJ, Wessel K. Neuro-protection by the metabolic antioxidant a-lipoic acid. Free Rad Biol Med 1997; 22: 359–378.PubMedCrossRefGoogle Scholar
  14. 14.
    Veggeberg S. High performance antioxidants for a multitude of diseases. Mol Med Today 1996; 406–409.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • Irène Ceballos-Picot
    • 1
  1. 1.Hôpital NeckerParisFrance

Personalised recommendations